...in healthy volunteers. The compound has Orphan Drug designation in the U.S. for the indication. NephRx Corp....

...saline-treated controls (p=0.001). NX002 is a peptide derived from the gastric growth factor AMP-18 . NephRx Corp....

...FDA granted Orphan Drug designation for NephRx's NX001 to prevent delayed graft function in renal transplant...
...peptide is in preclinical development with Phase I testing expected to begin by year end. NephRx Corp....

...Not available Midway Pharmaceuticals Inc. Therapeutics for GI tract diseases 2005 Spring House, Pa. $500K NephRx Corp....